Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSlingsby H.c Regulatory News (SLNG)

  • There is currently no data for SLNG

Update Regarding Retirement Benefits Scheme

26 Mar 2024 07:00

RNS Number : 2264I
Slingsby(H.C.)Plc
26 March 2024
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT CONSTITUTES INSIDE INFORMATION AS DEFINED BY THE MARKET ABUSE REGULATIONS (EU) NO. 596/2014, WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

26 March 2024

 

H C SLINGSBY PLC

("Slingsby", "the Group" or the "Company")

 

Update Regarding Retirement Benefits Scheme

 

HC Slingsby PLC, one of the market leaders in the distribution of industrial and commercial equipment, provides the following update in respect of its defined benefit pension scheme, the H.C. Slingsby PLC Retirement Benefits Scheme ("the Scheme").

 

The Company has agreed a new Schedule of Contributions and Recovery Plan with the Trustee of the Scheme pursuant to the requirements of the Pension Act 1995 ("the New Trustee Agreement") which replaces previous Scheme funding obligations. 

 

The actuarial valuation of the Scheme as at 1 January 2023 showed a funding shortfall (technical provisions minus value of assets) of approximately £7.2 million (30 June 2019: funding shortfall of £10.5m).

 

Under the New Trustee Agreement, the Company is scheduled to pay:

 

- £5,222 per month from 1 April 2024 to 31 December 2024;

- £29,167 per month from 1 January 2025 to 31 December 2025;

- £33,333 per month from 1 January 2026 to 31 December 2026; and

- £37,500 per month from 1 January 2027 until the shortfall has been met, increasing annually at each 1 July by 3%.

 

The phasing of deficit reduction contributions above, represents a short-to medium term total cash saving to the Group over the years 2024, 2025 and 2026 of approximately £390,000 when compared to the previous arrangement. This re-phasing of deficit reduction contributions, whilst improving the Group's shorter-term cash outlook, does not alter the Company's obligation to fund the Scheme's shortfall in its entirety.

 

Over January 2023 to June 2023 Slingsby made contributions of £33,334 per month to the Scheme and from July 2023 to March 2024, the Company made contributions of £34,334 per month.

 

The Company remains required to pay an additional contingent shortfall-correction contribution to the Scheme equal to 50% of the Group's cashflow in excess of £150,000 for each year (on the basis of the audited cashflow statement adjusted for any changes in borrowings). The payments due under the New Trustee Agreement will be reviewed no later than 15 months after 1 January 2026, the next actuarial valuation date of the Scheme.

 

The Company will also continue to pay up to £160,000 per annum towards the running costs of the Scheme.

 

The Company has undertaken not to make any distribution to shareholders prior to 1 June 2025 and has an obligation under its previous Trustee agreement to limit any distributions from 1 June 2025 onwards to an amount not greater than £60,000 plus 50% of its audited net cashflow (adjusted for any changes in borrowings). The Company remains obliged to consult with the Trustee regarding certain other matters but is not obliged to change its approach as a result.

 

 

For further information, please contact:

 

H C Slingsby PLC

Tel: 01274 535 030

Andrew Kitchingman, Non-Executive Chairman

Morgan Morris, Group Chief Executive

 

 

Allenby Capital Limited (Nominated adviser and Broker)

Tel: 020 3328 5656

Alex Brearley / George Payne (Corporate Finance)

Amrit Nahal (Sales and Corporate Broking)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCJAMRTMTJTBPI
Date   Source Headline
23rd Dec 20257:00 amRNSCancellation - Slingsby (H.C.) Plc
17th Dec 202512:50 pmRNSDirector/PDMR Shareholding
15th Dec 20252:14 pmRNSResult of General Meeting
24th Nov 20259:45 amRNSHolding(s) in Company
20th Nov 20257:00 amRNSProposed cancellation of admission to AIM
29th Jul 20251:39 pmRNSReplacement: Half-year Report
29th Jul 20257:00 amRNSHalf-year Report
23rd May 20252:02 pmRNSResult of Annual General Meeting
23rd May 20257:00 amRNSAGM statement
22nd Apr 202512:11 pmRNSPosting of Annual Report and Notice of AGM
7th Apr 20257:00 amRNSAudited Results for the year to 31 December 2024
1st Apr 20259:30 amRNSConclusion of formal sale process
4th Mar 20251:08 pmRNSForm 8.3 - H C Slingsby plc
24th Feb 20257:00 amRNSForm 8.3 - H C Slingsby plc
24th Feb 20257:00 amRNSForm 8.3 - H C Slingsby plc
21st Feb 20254:24 pmRNSForm 8.3 - H C Slingsby plc
20th Feb 20257:00 amRNSForm 8 (OPD) - H C Slingsby plc
17th Feb 20252:49 pmRNSForm 8.3 - H C Slingsby plc
17th Feb 20251:21 pmRNSForm 8.3 - H C Slingsby plc
13th Feb 20253:51 pmRNSForm 8.3 - H C Slingsby plc
11th Feb 202510:00 amRNSCommencement of Formal Sale Process
29th Nov 20245:00 pmRNSTotal Voting Rights
30th Oct 20247:00 amRNSIssue of Shares in Lieu of Bonus
15th Oct 20247:00 amRNSTrading Update
6th Aug 20247:00 amRNSReport for the half year ended 30 June 2024
19th Jun 20242:33 pmRNSResult of Annual General Meeting
19th Jun 20247:00 amRNSAGM statement
7th Jun 20241:54 pmRNSHolding(s) in Company
6th Jun 20242:37 pmRNSHolding(s) in Company
20th May 202411:34 amRNSPosting of Annual Report and Notice of AGM
26th Apr 20247:00 amRNSHolding(s) in Company
23rd Apr 20247:00 amRNSResults for the year ended 31 December 2023
26th Mar 20247:00 amRNSUpdate Regarding Retirement Benefits Scheme
12th Mar 20247:00 amRNSRetirement of Executive Director
13th Nov 202310:46 amRNSDirector/PDMR Shareholding
9th Nov 202312:45 pmRNSDirector/PDMR Shareholding
23rd Oct 20232:15 pmRNSDirector/PDMR Shareholding
29th Sep 202311:04 amRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSAppointment of Chairman
4th Aug 20237:00 amRNSHalf-year Report
15th Jun 20231:26 pmRNSResult of AGM
15th Jun 20237:00 amRNSTrading Update
16th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
2nd May 20237:00 amRNSResults for the year ended 31 December 2022
9th Dec 20221:00 pmRNSDirector/PDMR Shareholding
11th Aug 20229:25 amRNSDirector/PDMR Shareholding
4th Aug 20227:00 amRNSHalf-year Report
21st Jun 20221:22 pmRNSResult of AGM
21st Jun 20227:00 amRNSTrading Update
26th May 20221:31 pmRNSPosting of Accounts and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.